Skip to main content
. 2024 Dec 18;13:RP92418. doi: 10.7554/eLife.92418

Figure 5. Agonist and loop movements in the hold (flip and flop).

(A) Left, superimposed cartoons of ACL (m1; orange) and ACH (m3; blue). Loop C is upper left and loop F is lower right. In L→H (orange→blue) there is a cistrans reorientation of the agonist (flip) and a downward movement of loop C (flop, arrow). Right, agonist structure m1 (red) versus m2 (yellow) versus m3 (blue). Degree pertains to the m1→m3 pivot angle of the agonist.

Figure 5.

Figure 5—figure supplement 1. Conformational change of the pocket cavity accommodates agonist re-orientation.

Figure 5—figure supplement 1.

Red, low-affinity conformation (ACL); blue, high-affinity conformation (ACH). In ACL the ligand is cis and aromatic residues αY190, αY93, and δW57 are spread to accommodate the agonist’s tail. In ACH the ligand is trans and αY190 is positioned to fill the αY93-δW57 gap, creating a unified surface that restrains the ligand’s tail. Key residue sidechains are shown as spheres; the agonist is ball-and-stick.